Tilt Holdings marijuana vape subsidiary Jupiter Research refinances debt
Jupiter Research, a marijuana vape cartridge subsidiary of Phoenix-based Tilt Holdings, refinanced and extended its revolving credit facility.
News March 15
Latest In: Recreational
5 Canadian cannabis producers face May deadline in ‘extracts/edibles’ conflict
Health Canada has asked five companies to stop distribution and sale of noncompliant cannabis edibles products by the…
News March 15
Cannabis brands, products steeped in nostalgia aim to attract generational consumers
Cannabis companies nationwide are infusing a heavy dose of nostalgia in their products and building brands based on…
News March 15
Maryland adult-use marijuana bill heads to Senate after House approval
If an adult-use marijuana implementation bill passes the Maryland Senate, recreational sales in the state could begin this…
News March 14
Indiva pauses some production over cannabis ‘edibles’ dispute
Another Canadian cannabis producer has hit pause on the production of certain products because of a dispute with…
News March 14
Germany confident EU will approve rec cannabis legalization blueprint
German Health Minister Karl Lauterbach has expressed confidence that the country’s plan to legalize recreational cannabis might soon…
News March 14
Trademark lawsuit abandoned against marijuana MSO Green Thumb
Edible Arrangements officially ended its trademark lawsuit against marijuana multistate operator Green Thumb Industries.
News March 14
Oregon marijuana prices reach new lows amid oversupply issues
Retail and wholesale prices for legal marijuana in Oregon are at or near all-time lows as a cannabis oversupply…
News March 13
Organigram pauses some cannabis production over classification dispute
Canadian cannabis producer Organigram Holdings said it is pausing production of its lozenge product in a 100-milligram THC…
News March 13
Synthetic cannabinoids further rift between marijuana and hemp industries
A recent ruling from the U.S. Drug Enforcement Administration classifying a synthetic cannabinoid as a Schedule 1 drug…
News March 13
Latest Sponsored
